$2.68
-0.09[-3.25%]
At close: Apr 18
$2.68
0[0.00%]
After Hours: 7:46PM EDT
Heron Therapeutics
(NASDAQ:HRTX)Heron Therapeutics Stock (NASDAQ:HRTX), Earnings Estimates, EPS, and Revenue
Heron Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$32.8M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$127M
Analyze the earnings history of Heron Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | HRTX | Q1 | -$0.27 | -$0.09 | — | — | $29.61M | $32.80M | — | — | Get Alert |
| 03/12/2024 | PM | HRTX | Q4 | -$0.17 | -$0.16 | -$0.07 | 56.25% | $30.03M | $30.97M | $34.23M | 10.54% | Get Alert |
| 11/14/2023 | PM | HRTX | Q3 | -$0.38 | -$0.29 | -$0.17 | 41.38% | $26.56M | $32.75M | $31.43M | -4.02% | Get Alert |
| 08/14/2023 | PM | HRTX | Q2 | -$0.55 | -$0.23 | -$0.35 | -52.17% | $27.63M | $31.70M | $31.76M | 0.20% | Get Alert |
| 05/11/2023 | PM | HRTX | Q1 | -$0.63 | -$0.20 | -$0.27 | -35.00% | $23.46M | $29.69M | $29.61M | -0.25% | Get Alert |
| 03/23/2023 | PM | HRTX | Q4 | -$0.54 | -$0.28 | -$0.17 | 39.29% | $20.66M | $26.90M | $30.03M | 11.63% | Get Alert |
| 11/08/2022 | PM | HRTX | Q3 | -$0.51 | -$0.38 | -$0.38 | 0.00% | $23.23M | $26.96M | $26.56M | -1.49% | Get Alert |
| 08/09/2022 | AM | HRTX | Q2 | -$0.62 | -$0.50 | -$0.55 | -10.00% | $22.44M | $24.31M | $27.63M | 13.66% | Get Alert |
| 05/09/2022 | PM | HRTX | Q1 | -$0.58 | — | -$0.63 | — | $20.02M | — | $23.46M | — | Get Alert |
| 02/28/2022 | PM | HRTX | Q4 | -$0.68 | -$0.58 | -$0.54 | 6.90% | $20.61M | $25.59M | $20.66M | -19.28% | Get Alert |
| 11/03/2021 | PM | HRTX | Q3 | -$0.64 | -$0.61 | -$0.51 | 16.39% | $19.96M | $25.51M | $23.23M | -8.94% | Get Alert |
| 08/09/2021 | AM | HRTX | Q2 | -$0.61 | -$0.55 | -$0.62 | -12.73% | $22.67M | $29.39M | $22.44M | -23.64% | Get Alert |
| 05/10/2021 | AM | HRTX | Q1 | -$0.57 | -$0.55 | -$0.58 | -5.45% | $25.40M | $30.18M | $20.02M | -33.67% | Get Alert |
| 02/24/2021 | AM | HRTX | Q4 | -$0.65 | — | -$0.68 | — | $35.08M | — | $20.61M | — | Get Alert |
| 11/05/2020 | AM | HRTX | Q3 | -$0.42 | — | -$0.64 | — | $42.62M | — | $19.96M | — | Get Alert |
| 08/05/2020 | AM | HRTX | Q2 | -$0.63 | — | -$0.61 | — | $36.66M | — | $22.67M | — | Get Alert |
| 05/06/2020 | PM | HRTX | Q1 | -$0.80 | — | -$0.57 | — | $31.60M | — | $25.40M | — | Get Alert |
| 03/02/2020 | AM | HRTX | Q4 | -$0.63 | — | -$0.65 | — | $28.84M | — | $35.08M | — | Get Alert |
| 11/12/2019 | AM | HRTX | Q3 | -$0.49 | — | -$0.42 | — | $19.79M | — | $42.62M | — | Get Alert |
FAQ
When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?
Heron Therapeutics (HRTX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
What were the latest earnings per share (EPS) for Heron Therapeutics (NASDAQ:HRTX)?
The Actual EPS was $-0.07, which beat the estimate of $-0.16.
What were Heron Therapeutics’s (NASDAQ:HRTX) revenues?
The Actual Revenue was $34.2M, which beat the estimate of $31M.
Browse earnings estimates, EPS, and revenue on all stocks.